Avanos Medical
AVNS
291 hedge funds and large institutions have $1.92B invested in Avanos Medical in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 60 increasing their positions, 80 reducing their positions, and 33 closing their positions.
39% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 33
4% more funds holding
Funds holding: 281 → 291 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.56% less ownership
Funds ownership: 94.41% → 91.85% (-2.6%)
7% less capital invested
Capital invested by funds: $2.07B → $1.92B (-$142M)
25% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 80
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$13.5M |
| 2 |
Millennium Management
New York
|
+$11M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.87M |
| 4 |
TCM
Tygh Capital Management
Portland,
Oregon
|
+$5.28M |
| 5 |
JP Morgan Chase
New York
|
+$5.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$26.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$17.2M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$16.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.8M |
| 5 |
CSC
Cove Street Capital
El Segundo,
California
|
-$9.38M |
AVNS Hedge Fund Activity: Q1 2021 in Review
291 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2021, worth a combined $1.92B — down 6.9% from $2.07B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new AVNS positions and 33 closed out — a net gain of 13 holders — while 60 added to existing stakes and 80 trimmed.
The largest buyer was BlackRock, adding an estimated $13.5M. The largest seller was Champlain Investment Partners, cutting an estimated $26.2M.
- 291 institutional investors held Avanos Medical (AVNS) as of Q1 2021, up from 281 in Q4 2020.
- Funds reported $1.92B of Avanos Medical stock for Q1 2021, down 6.9% quarter-over-quarter.
- 46 funds opened new Avanos Medical positions in Q1 2021 and 33 closed out, a net change of +13 holders.
- The largest Avanos Medical buyer in Q1 2021 was BlackRock, an estimated $13.5M added.
- The largest Avanos Medical seller in Q1 2021 was Champlain Investment Partners, an estimated $26.2M sold.
Based on aggregated 13F filings for Q1 2021.